BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: White Z, Hakim CH, Theret M, Yang NN, Rossi F, Cox D, Francis GA, Straub V, Selby K, Panagiotopoulos C, Duan D, Bernatchez P. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia. J Clin Lipidol 2020;14:459-469.e0. [PMID: 32593511 DOI: 10.1016/j.jacl.2020.05.098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Khattri RB, Batra A, Matheny M, Hart C, Henley-Beasley SC, Hammers D, Zeng H, White Z, Ryan TE, Barton E, Bernatchez P, Walter GA. Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy. NMR Biomed 2023;36:e4869. [PMID: 36331178 DOI: 10.1002/nbm.4869] [Reference Citation Analysis]
2 White Z, Sun Z, Sauge E, Cox D, Donen G, Pechkovsky D, Straub V, Francis GA, Bernatchez P. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice. Skelet Muscle 2022;12:25. [PMID: 36447272 DOI: 10.1186/s13395-022-00308-6] [Reference Citation Analysis]
3 Podkalicka P, Mucha O, Kaziród K, Szade K, Stępniewski J, Ivanishchuk L, Hirao H, Pośpiech E, Józkowicz A, Kupiec-Weglinski JW, Dulak J, Łoboda A. miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy. Sci Rep 2022;12:3945. [PMID: 35273230 DOI: 10.1038/s41598-022-07868-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Morris CE, Wheeler JJ, Joos B. The Donnan-dominated resting state of skeletal muscle fibers contributes to resilience and longevity in dystrophic fibers. J Gen Physiol 2022;154:e202112914. [PMID: 34731883 DOI: 10.1085/jgp.202112914] [Reference Citation Analysis]
5 White Z, Theret M, Milad N, Tung LW, Chen WW, Sirois MG, Rossi F, Bernatchez P. Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice. J cachexia sarcopenia muscle. [DOI: 10.1002/jcsm.12879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 White Z, Milad N, Sellers SL, Bernatchez P. Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions. Front Physiol 2021;12:675322. [PMID: 34366880 DOI: 10.3389/fphys.2021.675322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tsonaka R, Seyer A, Aartsma-Rus A, Spitali P. Plasma lipidomic analysis shows a disease progression signature in mdx mice. Sci Rep 2021;11:12993. [PMID: 34155298 DOI: 10.1038/s41598-021-92406-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Amor F, Vu Hong A, Corre G, Sanson M, Suel L, Blaie S, Servais L, Voit T, Richard I, Israeli D. Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy. J Cachexia Sarcopenia Muscle 2021;12:677-93. [PMID: 34037326 DOI: 10.1002/jcsm.12708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
9 Theret M, Low M, Rempel L, Li FF, Tung LW, Contreras O, Chang CK, Wu A, Soliman H, Rossi FMV. In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy. Life Sci 2021;279:119482. [PMID: 33891939 DOI: 10.1016/j.lfs.2021.119482] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Theret M, Low M, Rempel L, Li FF, Tung LW, Contreras O, Chang C, Wu A, Soliman H, Rossi FM. Targeting fibrosis in the Duchenne Muscular Dystrophy mice model: an uphill battle.. [DOI: 10.1101/2021.01.20.427485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Fei W, Liu M, Zhang Y, Cao S, Wang X, Xie B, Wang J. Identification of key pathways and hub genes in the myogenic differentiation of pluripotent stem cell: a bioinformatics and experimental study. J Orthop Surg Res 2021;16:4. [PMID: 33397419 DOI: 10.1186/s13018-020-01979-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]